These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 24183309)

  • 81. Phenotypic variability of a TREX1 variant in Aicardi-Goutieres type 1 patients from the Indian subcontinent.
    Abraham SSC; Yoganathan S; Koshy B; Oommen SP; Simon A; Mathai S; Korula S; Mathew L; Sathishkumar D; Jasper A; George R; Danda S
    Eur J Med Genet; 2021 Sep; 64(9):104291. PubMed ID: 34303877
    [TBL] [Abstract][Full Text] [Related]  

  • 82. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.
    Clifford R; Louis T; Robbe P; Ackroyd S; Burns A; Timbs AT; Wright Colopy G; Dreau H; Sigaux F; Judde JG; Rotger M; Telenti A; Lin YL; Pasero P; Maelfait J; Titsias M; Cohen DR; Henderson SJ; Ross MT; Bentley D; Hillmen P; Pettitt A; Rehwinkel J; Knight SJ; Taylor JC; Crow YJ; Benkirane M; Schuh A
    Blood; 2014 Feb; 123(7):1021-31. PubMed ID: 24335234
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Spontaneous MRI improvement and absence of cerebral calcification in Aicardi-Goutières syndrome: Diagnostic and disease-monitoring implications.
    Tonduti D; Izzo G; D'Arrigo S; Riva D; Moroni I; Zorzi G; Cavallera V; Pichiecchio A; Uggetti C; Veggiotti P; Orcesi S; Chiapparini L; Parazzini C
    Mol Genet Metab; 2019 Apr; 126(4):489-494. PubMed ID: 30826161
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutières syndrome.
    Tüngler V; Silver RM; Walkenhorst H; Günther C; Lee-Kirsch MA
    Br J Dermatol; 2012 Jul; 167(1):212-4. PubMed ID: 22356656
    [No Abstract]   [Full Text] [Related]  

  • 85. Exploration of Gross Motor Function in Aicardi-Goutières Syndrome.
    Gavazzi F; Glanzman AM; Woidill S; Formanowski B; Dixit A; Isaacs D; Kornafel T; Ballance E; Pierce SR; Modesti N; Barcelos I; Cusack SV; Jan AK; Flores Z; Sherbini O; Vincent A; D'Aiello R; Lorch SA; DeMauro SB; Jawad A; Vanderver A; Adang L
    J Child Neurol; 2023 Aug; 38(8-9):518-527. PubMed ID: 37499181
    [No Abstract]   [Full Text] [Related]  

  • 86. The importance of chilblains as a diagnostic clue for mild Aicardi-Goutières syndrome.
    Yarbrough K; Danko C; Krol A; Zonana J; Leitenberger S
    Am J Med Genet A; 2016 Dec; 170(12):3308-3312. PubMed ID: 27604406
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Differential Expression of Interferon-Alpha Protein Provides Clues to Tissue Specificity Across Type I Interferonopathies.
    Lodi L; Melki I; Bondet V; Seabra L; Rice GI; Carter E; Lepelley A; Martin-Niclós MJ; Al Adba B; Bader-Meunier B; Barth M; Blauwblomme T; Bodemer C; Boespflug-Tanguy O; Dale RC; Desguerre I; Ducrocq C; Dulieu F; Dumaine C; Ellul P; Hadchouel A; Hentgen V; Hié M; Hully M; Jeziorski E; Lévy R; Mochel F; Orcesi S; Passemard S; Pouletty M; Quartier P; Renaldo F; Seidl R; Shetty J; Neven B; Blanche S; Duffy D; Crow YJ; Frémond ML
    J Clin Immunol; 2021 Apr; 41(3):603-609. PubMed ID: 33411153
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Characterization of six recombinant human RNase H2 bearing Aicardi-Goutiéres syndrome causing mutations.
    Nishimura T; Baba M; Ogawa S; Kojima K; Takita T; Crouch RJ; Yasukawa K
    J Biochem; 2019 Dec; 166(6):537-545. PubMed ID: 31529068
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response.
    Rice GI; Bond J; Asipu A; Brunette RL; Manfield IW; Carr IM; Fuller JC; Jackson RM; Lamb T; Briggs TA; Ali M; Gornall H; Couthard LR; Aeby A; Attard-Montalto SP; Bertini E; Bodemer C; Brockmann K; Brueton LA; Corry PC; Desguerre I; Fazzi E; Cazorla AG; Gener B; Hamel BC; Heiberg A; Hunter M; van der Knaap MS; Kumar R; Lagae L; Landrieu PG; Lourenco CM; Marom D; McDermott MF; van der Merwe W; Orcesi S; Prendiville JS; Rasmussen M; Shalev SA; Soler DM; Shinawi M; Spiegel R; Tan TY; Vanderver A; Wakeling EL; Wassmer E; Whittaker E; Lebon P; Stetson DB; Bonthron DT; Crow YJ
    Nat Genet; 2009 Jul; 41(7):829-32. PubMed ID: 19525956
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Late-Onset Aicardi-Goutières Syndrome: A Characterization of Presenting Clinical Features.
    Piccoli C; Bronner N; Gavazzi F; Dubbs H; De Simone M; De Giorgis V; Orcesi S; Fazzi E; Galli J; Masnada S; Tonduti D; Varesio C; Vanderver A; Vossough A; Adang L
    Pediatr Neurol; 2021 Feb; 115():1-6. PubMed ID: 33307271
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Aicardi-Goutières syndrome: an important Mendelian mimic of congenital infection.
    Crow YJ; Livingston JH
    Dev Med Child Neurol; 2008 Jun; 50(6):410-6. PubMed ID: 18422679
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Modulation of LINE-1 and Alu/SVA retrotransposition by Aicardi-Goutières syndrome-related SAMHD1.
    Zhao K; Du J; Han X; Goodier JL; Li P; Zhou X; Wei W; Evans SL; Li L; Zhang W; Cheung LE; Wang G; Kazazian HH; Yu XF
    Cell Rep; 2013 Sep; 4(6):1108-15. PubMed ID: 24035396
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome/familial chilblain lupus.
    Abe J; Izawa K; Nishikomori R; Awaya T; Kawai T; Yasumi T; Hiragi N; Hiragi T; Ohshima Y; Heike T
    Rheumatology (Oxford); 2013 Feb; 52(2):406-8. PubMed ID: 22829693
    [No Abstract]   [Full Text] [Related]  

  • 94. Combination of exome sequencing and immune testing confirms Aicardi-Goutières syndrome type 5 in a challenging pediatric neurology case.
    Haskell GT; Mori M; Powell C; Amrhein TJ; Rice GI; Bailey L; Strande N; Weck KE; Evans JP; Berg JS; Kishnani P
    Cold Spring Harb Mol Case Stud; 2018 Oct; 4(5):. PubMed ID: 30275001
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Relapsing-remitting clinical course expands the phenotype of Aicardi-Goutières syndrome.
    Lambe J; Murphy OC; Mu W; Sondergaard Schatz K; Barañano KW; Venkatesan A
    Ann Clin Transl Neurol; 2020 Feb; 7(2):254-258. PubMed ID: 31920009
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Characterization of Mitochondrial Alterations in Aicardi-Goutières Patients Mutated in
    Dragoni F; Garau J; Sproviero D; Orcesi S; Varesio C; De Siervi S; Gagliardi S; Cereda C; Pansarasa O
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430958
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Genotype-Phenotype Correlation and Functional Insights for Two Monoallelic
    Amico G; Hemphill WO; Severino M; Moratti C; Pascarella R; Bertamino M; Napoli F; Volpi S; Rosamilia F; Signa S; Perrino F; Zedde M; Ceccherini I; On Behalf Of The Gaslini Stroke Study Group
    Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885962
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase.
    Powell RD; Holland PJ; Hollis T; Perrino FW
    J Biol Chem; 2011 Dec; 286(51):43596-43600. PubMed ID: 22069334
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy.
    Nakahama T; Kato Y; Shibuya T; Inoue M; Kim JI; Vongpipatana T; Todo H; Xing Y; Kawahara Y
    Immunity; 2021 Sep; 54(9):1976-1988.e7. PubMed ID: 34525338
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Molecular characterization of an intronic RNASEH2B variant in a patient with Aicardi-Goutières syndrome.
    Leung ML; Woodhull W; Uggenti C; Schord S; Mato RP; Rodriguez DP; Ream M; Crow YJ; Mori M
    Eur J Med Genet; 2023 Apr; 66(4):104731. PubMed ID: 36775013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.